Syndax Pharmaceuticals (1T3.MU) Q1 2026 Earnings

26FebConfirmed
Q1 2026
-0.66
-0.61
-0.55
-0.49

Details

Expected EPS
-0.49487131475999996
Actual EPS
-0.6609096
Surprise EPS
-0.17
Surprise Percent
+33.55%

Description

Syndax Pharmaceuticals (1T3.MU) has reported earnings of -0.6609096 per share for Q1 2026.

0 Comments

Share your thoughts